Bruker (BRKR) revenue breakdown
By segment, BSI CALID is the largest at 35% of fiscal 2025 revenue, growing 12% a year over 7 years.
By product, Product revenue is the largest at 81% of fiscal 2025 revenue; Service and other revenue grew fastest, 58% a year over 9 years.
Revenue by segment
Fiscal years, as Bruker reports them in its 10-K filings; fiscal 2025 total $3.4B.
| Segments | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BSI CALID | — | — | $548M | $624M | $654M | $820M | $822M | $960M | $1.1B | $1.2B | 35% |
| BSI NANO | — | — | $568M | $633M | $556M | $698M | $787M | $942M | $1.1B | $1.1B | 32% |
| BSI BioSpin | — | — | $591M | $621M | $600M | $691M | $697M | $798M | $906M | $879M | 26% |
| BEST | $130M | $191M | $195M | $210M | $190M | $224M | $225M | $264M | $269M | $263M | 8% |
| BSI | $1.5B | $1.6B | — | — | — | — | — | — | — | — | — |
Revenue by product
Fiscal years, as Bruker reports them in its 10-K filings; fiscal 2025 total $3.4B.
| Products | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Product revenue | $1.3B | $1.5B | $1.6B | $1.7B | $1.6B | $2.0B | $2.1B | $2.5B | $2.8B | $2.8B | 81% |
| Service and other revenue | $11M | $8M | $7M | $6M | $6M | $7M | $421M | $507M | $607M | $670M | 19% |
| Service | $255M | $278M | $312M | $322M | $343M | $393M | — | — | — | — | — |
Revenue by region
Fiscal years, as Bruker reports them in its 10-K filings; fiscal 2025 total $3.4B.
| Regions | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Europe Excluding Germany | $393M | $465M | $500M | $505M | $520M | $658M | $592M | $700M | $873M | $950M | 28% |
| United States | $428M | $435M | $489M | $530M | $456M | $601M | $696M | $778M | $938M | $891M | 26% |
| Asia Pacific Excluding China | $458M | $515M | $549M | $651M | $316M | $372M | $408M | $461M | $518M | $553M | 16% |
| China | — | — | — | — | $314M | $358M | $396M | $528M | $471M | $476M | 14% |
| Germany | $190M | $200M | $201M | $214M | $245M | $263M | $247M | $282M | $311M | $297M | 9% |
| Other | $142M | $151M | $156M | $173M | $138M | $167M | $190M | $217M | $254M | $270M | 8% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for BRKR.
Open BRKR in InvestinglyQuestions
Where does Bruker make its money?
In fiscal 2025, by segment: BSI CALID $1.2B, BSI NANO $1.1B, BSI BioSpin $879M, BEST $263M.
From Bruker's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.